146 related articles for article (PubMed ID: 33819548)
1. Testing in vitro tools for the prediction of cholestatic liver injury induced by non-pharmaceutical chemicals.
Gijbels E; Devisscher L; Vinken M
Food Chem Toxicol; 2021 Jun; 152():112165. PubMed ID: 33819548
[TBL] [Abstract][Full Text] [Related]
2. Industrial, Biocide, and Cosmetic Chemical Inducers of Cholestasis.
Vilas-Boas V; Gijbels E; Cooreman A; Van Campenhout R; Gustafson E; Leroy K; Vinken M
Chem Res Toxicol; 2019 Jul; 32(7):1327-1334. PubMed ID: 31243985
[TBL] [Abstract][Full Text] [Related]
3. Dataset on transcriptomic profiling of cholestatic liver injury induced by food additives and a cosmetic ingredient.
Gijbels E; Devisscher L; Vinken M
Data Brief; 2021 Oct; 38():107373. PubMed ID: 34589561
[TBL] [Abstract][Full Text] [Related]
4. Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals.
Vilas-Boas V; Gijbels E; Leroy K; Pieters A; Baze A; Parmentier C; Vinken M
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681664
[TBL] [Abstract][Full Text] [Related]
5. Tartrazine and sunset yellow are xenoestrogens in a new screening assay to identify modulators of human oestrogen receptor transcriptional activity.
Axon A; May FE; Gaughan LE; Williams FM; Blain PG; Wright MC
Toxicology; 2012 Aug; 298(1-3):40-51. PubMed ID: 22562034
[TBL] [Abstract][Full Text] [Related]
6. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
[TBL] [Abstract][Full Text] [Related]
7. Rat precision-cut liver slices predict drug-induced cholestatic injury.
Starokozhko V; Greupink R; van de Broek P; Soliman N; Ghimire S; de Graaf IAM; Groothuis GMM
Arch Toxicol; 2017 Oct; 91(10):3403-3413. PubMed ID: 28391356
[TBL] [Abstract][Full Text] [Related]
8. Latest advances on the nanomaterials-based electrochemical analysis of azo toxic dyes Sunset Yellow and Tartrazine in food samples.
Kaya SI; Cetinkaya A; Ozkan SA
Food Chem Toxicol; 2021 Oct; 156():112524. PubMed ID: 34454997
[TBL] [Abstract][Full Text] [Related]
9. Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis.
Van den Hof WFPM; Coonen MLJ; van Herwijnen M; Brauers K; Jennen D; Olde Damink SWM; Schaap FG; Kleinjans JCS
Toxicol In Vitro; 2017 Oct; 44():322-329. PubMed ID: 28778767
[TBL] [Abstract][Full Text] [Related]
10. Lack of genotoxic effect of food dyes amaranth, sunset yellow and tartrazine and their metabolites in the gut micronucleus assay in mice.
Poul M; Jarry G; Elhkim MO; Poul JM
Food Chem Toxicol; 2009 Feb; 47(2):443-8. PubMed ID: 19095036
[TBL] [Abstract][Full Text] [Related]
11. Case report: mixed cholestatic/hepatocellular liver injury induced by the herbicide quizalofop-p-ethyl.
Elefsiniotis IS; Liatsos GD; Stamelakis D; Moulakakis A
Environ Health Perspect; 2007 Oct; 115(10):1479-81. PubMed ID: 17938739
[TBL] [Abstract][Full Text] [Related]
12. Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent.
Parmentier C; Hendriks DFG; Heyd B; Bachellier P; Ingelman-Sundberg M; Richert L
Toxicol Lett; 2018 Oct; 295():187-194. PubMed ID: 29913214
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms and in vitro models of drug-induced cholestasis.
Gijbels E; Vilas-Boas V; Deferm N; Devisscher L; Jaeschke H; Annaert P; Vinken M
Arch Toxicol; 2019 May; 93(5):1169-1186. PubMed ID: 30972450
[TBL] [Abstract][Full Text] [Related]
14. [Mutagenicity testing of some azo dyes used as food additives].
Izbirak A; Sümer S; Diril N
Mikrobiyol Bul; 1990 Jan; 24(1):48-56. PubMed ID: 2283964
[TBL] [Abstract][Full Text] [Related]
15. Effects of diet on growth and survival of rats fed toxic levels of tartrazine (FD & C Yellow No. 5) and sunset yellow FCF (FD & C Yellow No. 6).
Ershoff BH
J Nutr; 1977 May; 107(5):822-8. PubMed ID: 859044
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced cholestasis.
Bhamidimarri KR; Schiff E
Clin Liver Dis; 2013 Nov; 17(4):519-31, vii. PubMed ID: 24099015
[TBL] [Abstract][Full Text] [Related]
17. Pyrazinamide Induced Rat Cholestatic Liver Injury through Inhibition of FXR Regulatory Effect on Bile Acid Synthesis and Transport.
Guo HL; Hassan HM; Zhang Y; Dong SZ; Ding PP; Wang T; Sun LX; Zhang LY; Jiang ZZ
Toxicol Sci; 2016 Aug; 152(2):417-28. PubMed ID: 27255380
[TBL] [Abstract][Full Text] [Related]
18. Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury.
Gijbels E; Vilas-Boas V; Annaert P; Vanhaecke T; Devisscher L; Vinken M
Arch Toxicol; 2020 Apr; 94(4):1151-1172. PubMed ID: 32152650
[TBL] [Abstract][Full Text] [Related]
19. Hepatic effects of tartrazine (E 102) after systemic exposure are independent of oestrogen receptor interactions in the mouse.
Meyer SK; Probert PME; Lakey AF; Axon AR; Leitch AC; Williams FM; Jowsey PA; Blain PG; Kass GEN; Wright MC
Toxicol Lett; 2017 May; 273():55-68. PubMed ID: 28356238
[TBL] [Abstract][Full Text] [Related]
20. A Novel MicroRNA Signature for Cholestatic Drugs in Human Hepatocytes and Its Translation into Novel Circulating Biomarkers for Drug-Induced Liver Injury Patients.
López-Riera M; Conde I; Castell JV; Jover R
Toxicol Sci; 2020 Feb; 173(2):229-243. PubMed ID: 31198949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
